Basis: Trailing twelve months (TTM net income over TTM revenue). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the net profit margin high or low?
The net profit margin of -122.42% is in line with its 5-year average of -116.90%, around the middle of its 5-year range (-181.85%–-44.15%).
5.81% above its 12-month average of -129.97%.
Reported quarterly profit margin; no daily interpolation. Q2 FY2026 (2026-06-30): -106.37%.
NET PROFIT MARGIN
-122.42%
NET PROFIT MARGIN AVG TTM
-129.97%
NET PROFIT MARGIN AVG 3Y
-110.55%
NET PROFIT MARGIN AVG 5Y
-116.90%
NET PROFIT MARGIN AVG 10Y
N/A
NET PROFIT MARGIN AVG 15Y
N/A
NET PROFIT MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
+5.81%
CURRENT VS 3Y AVG
-10.73%
CURRENT VS 5Y AVG
-4.72%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-0.26%
median of 863 covered companies
CURRENT VS SECTOR MEDIAN
-46984.62%
vs the sector median at left
Vivos Therapeutics, Inc.
Market Cap
$2.14M
Net Profit Margin
-122.42%
TTM Avg
-129.97%
3Y Avg
-110.55%
5Y Avg
-116.90%
Market Cap
$2.11M
Net Profit Margin
-862.34%
TTM Avg
-747.16%
3Y Avg
-4673.17%
5Y Avg
-3945.34%
Market Cap
$2.30M
Net Profit Margin
-201355.37%
TTM Avg
-74928.77%
3Y Avg
-55011.63%
5Y Avg
-36705.99%
Market Cap
$2.35M
Net Profit Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$1.93M
Net Profit Margin
-435.71%
TTM Avg
-845.71%
3Y Avg
-1722.30%
5Y Avg
-1584.91%
Market Cap
$2.36M
Net Profit Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$2.37M
Net Profit Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$2.37M
Net Profit Margin
-1578.79%
TTM Avg
-2023.10%
3Y Avg
-17008.17%
5Y Avg
-11338.78%
Market Cap
$1.89M
Net Profit Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
| NAME | MARKET CAP | NET PROFIT MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Vivos Therapeutics, Inc. (VVOS) | $2.14M | -122.42% | -129.97% | -110.55% | -116.90% |
| GeoVax Labs, Inc. (GOVX)vs › | $2.11M | -862.34% | -747.16% | -4673.17% | -3945.34% |
| Creative Medical Technology Holdings, Inc. (CELZ)vs › | $2.30M | -201355.37% | -74928.77% | -55011.63% | -36705.99% |
| Moleculin Biotech, Inc. (MBRX)vs › | $2.35M | 0.00% | 0.00% | 0.00% | 0.00% |
| Beyond Air, Inc. (XAIR)vs › | $1.93M | -435.71% | -845.71% | -1722.30% | -1584.91% |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH)vs › | $2.36M | 0.00% | 0.00% | 0.00% | 0.00% |
| FibroBiologics, Inc. Common Stock (FBLG)vs › | $2.37M | 0.00% | 0.00% | 0.00% | 0.00% |
| Onconetix, Inc. (ONCO)vs › | $2.37M | -1578.79% | -2023.10% | -17008.17% | -11338.78% |
| Autonomix Medical, Inc. (AMIX)vs › | $1.89M | 0.00% | 0.00% | 0.00% | 0.00% |
| Tenon Medical, Inc. (TNON)vs › | $1.89M | -256.33% | -367.80% | -1001.34% | -1624.30% |
Operating Margin
-107.9%
Net Profit Margin
-122.4%
Net Profit Margin = Net Income / Revenue
Net profit margin is the percentage of revenue that becomes net income after all expenses, taxes, and interest.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | NET PROFIT MARGIN |
|---|---|
| 2026-06-30 | -106.37% |
| 2026-03-31 | -150.77% |
| 2025-12-31 | -181.85% |
| 2025-09-30 | -79.61% |
| 2025-06-30 | -131.23% |
| 2025-03-31 | -128.12% |
| 2024-12-31 | -76.45% |
| 2024-09-30 | -67.77% |
| 2024-06-30 | -47.61% |
| 2024-03-31 | -110.06% |
| 2023-12-31 | -131.13% |
| 2023-09-30 | -63.41% |
| 2023-06-30 | -162.83% |
| 2023-03-31 | -44.15% |
| 2022-12-31 | -154.15% |
| 2022-09-30 | -127.98% |
| 2022-06-30 | -167.11% |
| 2022-03-31 | -146.30% |
| 2021-12-31 | -168.24% |
| 2021-09-30 | -119.95% |
| 2021-06-30 | -89.90% |
| 2021-03-31 | -98.58% |
| 2020-12-31 | -188.98% |
| 2020-09-30 | -55.08% |
| 2020-06-30 | -43.22% |
| 2020-03-31 | -80.73% |
| 2019-12-31 | -85.97% |
| 2019-09-30 | -93.25% |
| 2019-06-30 | -110.23% |
| 2019-03-31 | -110.23% |
